Ultragenyx Pharmaceutical Inc.
Veridion Score
Composite trend over time
Why is RARE moving today?
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. The company identifies, acquires, develops, and commercializes novel products for the treatment of serious, rare, and ultra-rare diseases, with a focus on debilitating genetic conditions. Its medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients aged one year and older. Mepsevii is indicated for pediatric and adult patients for the treatment of Mucopolysaccharidosis VII. The company operates across North America, Latin America, Europe, the Middle East and Africa, and Asia-Pacific, with the majority of its revenue generated from North America.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for RARE.
RARE insider activity
Ultragenyx Pharmaceutical Inc.
No multi-insider buying cluster in the last 90 days
Net selling: -$3.7M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 | 2026-06-15 | Sanders Corazon (Corsee) D. | Insider | sell | $25.05 | 2,000 | 21,095 | $50K | SEC Form 4 |
| 2026-06-15 | 2026-06-15 | Parschauer Karah Herdman | Insider | sell | $24.62 | 1,899 | 94,462 | $47K | SEC Form 4 |
| 2026-06-01 | 2026-06-01 | Horn Howard | Insider | sell | $23.77 | 4,653 | 105,689 | $111K | SEC Form 4 |
| 2026-05-18 | 2026-05-18 | SULIMAN SHEHNAAZ | Insider | sell | $25.12 | 5,740 | 27,951 | $144K | SEC Form 4 |
| 2026-05-06 | 2026-05-05 | Crombez Eric | Insider | sell | $24.96 | 344 | 111,189 | $9K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 23 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moRARE contract awards, year to date.
Public federal awards linked to this ticker.
RARE lobbying filings, year to date.
Registered lobbying filings matched to Ultragenyx Pharmaceutical Inc..